While some may see the recent decision of the Court of Justice of the EU that states that organisms obtained by mutagenesis are GMOs and are therefore subject to obligations laid down by the GMO directive as a win for consumers, the reality is just the opposite, writes Neal Gutterson.
‘Evidence-based policy-making’ constitutes one of the key slogans of the Juncker Commission and the Better Regulation agenda. But reality reveals a wide gap between theory and practice, writes Daniel Guéguen.
This week the representatives of the world's most advanced economies grapple with complex challenges at the G7 summit. Smart investments need to be made to solve the five key issues addressed at the summit and the smartest investment is in agricultural research, writes Marcon Ferroni.
When is a genetically modified organism (GMO) not a GMO? This is the question that the ECJ will soon rule on after a complaint from a coalition of French agriculture groups reached the EU’s highest court, writes Mute Schimpf.
Barely six years old, the EU’s Bioeonomy Strategy, currently under revision, is slowly but surely propagating green shoots of sustainable economic recovery in innumerable and unexpected ways, writes Joanna Dupont.
The lack of funding needed to achieve Europe's widely advertised ambitions for global excellence in research and innovation should be addressed in discussing Horizon 2020’s successor. Understanding the challenge and where the money could realistically come from is key, writes Thomas Estermann.